These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2412005)

  • 21. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions with cardiovascular drugs.
    Opie LH
    Curr Probl Cardiol; 1993 Sep; 18(9):531-81. PubMed ID: 7900972
    [No Abstract]   [Full Text] [Related]  

  • 23. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
    Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR
    J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local and cellular Ca2+ transients in smooth muscle of pressurized rat resistance arteries during myogenic and agonist stimulation.
    Miriel VA; Mauban JR; Blaustein MP; Wier WG
    J Physiol; 1999 Aug; 518 ( Pt 3)(Pt 3):815-24. PubMed ID: 10420017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactions between antihypertensive drugs].
    Takagi M; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN
    Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of methyclothiazide on the entry of calcium into vascular smooth muscle cells].
    Colas B; Colas JL; Masson H; Slama M; Collin T; Andrejak M
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):901-4. PubMed ID: 10989727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tailoring the antihypertensive drug regimen.
    Amadio P; Cummings DM; Amadio PB
    Am Fam Physician; 1986 Aug; 34(2):157-70. PubMed ID: 2875638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and ocular vascular roles of the antiglaucoma agents beta-adrenergic antagonists and Ca2+ entry blockers.
    Yu DY; Su EN; Cringle SJ; Alder VA; Yu PK; DeSantis L
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S214-22. PubMed ID: 10416766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
    Höcht C; Bertera FM; Mayer MA; Taira CA
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antihypertensive drugs on lipid metabolism.
    Leren P
    Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interactions between anti-hypertensive and non-antihypertensive drugs].
    Sugimoto T; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():28-33. PubMed ID: 1355128
    [No Abstract]   [Full Text] [Related]  

  • 34. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive therapy: newer concepts and agents.
    Frohlich ED
    Cardiology; 1985; 72(5-6):349-65. PubMed ID: 2866842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of calcium antagonists.
    Godfraind T
    Am J Cardiol; 1987 Jan; 59(3):11B-23B. PubMed ID: 2433928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal consequences of antihypertensive therapy.
    Eknoyan G; Suki WN
    Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK; Neuman SL
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review: the effects of antihypertensive agents on serum lipids.
    Madu EC; Reddy RC; Madu AN; Anyaogu C; Harris T; Fraker TD
    Am J Med Sci; 1996 Aug; 312(2):76-84. PubMed ID: 8701970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.